Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | Axonics, Inc. AXNX | The Vanguard Group | 5,260,830 10.380% | 167,942 (+3.30%) | Filing History |
| 2024-02-12 12:03 pm Sale | 2024-02-09 | 13G | Axonics, Inc. AXNX | FMR LLC | 1,179,132 2.322% | -4,246,873 (-78.27%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Axonics, Inc. AXNX | FMR LLC | 5,426,005 10.710% | -91,421 (-1.66%) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Axonics, Inc. AXNX | BlackRock Inc. BLK | 4,189,817 8.300% | 558,974 (+15.40%) | Filing History |
| 2023-12-11 09:09 am Purchase | 2023-12-08 | 13G | Axonics, Inc. AXNX | FMR LLC | 5,517,426 10.890% | 2,798,634 (+102.94%) | Filing History |
| 2023-03-10 07:59 am Purchase | 2023-02-28 | 13G | Axonics, Inc. AXNX | The Vanguard Group | 5,092,888 10.280% | 229,605 (+4.72%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Axonics, Inc. AXNX | The Vanguard Group | 4,863,283 9.820% | 1,960,587 (+67.54%) | Filing History |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | Axonics, Inc. AXNX | FMR LLC | 2,718,792 5.489% | -1,200,592 (-30.63%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Axonics, Inc. AXNX | BlackRock Inc. BLK | 3,630,843 7.300% | 105,294 (+2.99%) | Filing History |
| 2022-06-06 06:06 am Sale | 2022-06-06 | 13G | Axonics, Inc. AXNX | Cooperatieve Gilde Healthcare IV U.A. | 0 0.000% | -1,376,733 (Position Closed) | Filing History |
| 2022-02-14 1:11 pm Sale | 2021-12-31 | 13G | Axonics, Inc. AXNX | CREDIT SUISSE AG | 2,273,198 4.900% | -257,783 (-10.19%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Axonics, Inc. AXNX | The Vanguard Group | 2,902,696 6.270% | 2,902,696 (New Position) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Axonics, Inc. AXNX | FMR LLC | 3,919,384 8.465% | -938,522 (-19.32%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Axonics, Inc. AXNX | BlackRock Inc. BLK | 3,525,549 7.600% | 1,246,316 (+54.68%) | Filing History |
| 2021-04-08 4:32 pm Sale | 2020-12-31 | 13G | Axonics, Inc. AXNX | Alfred E. Mann Foundation for Scientific Research | 1,602,970 4.000% | -224,598 (-12.29%) | Filing History |
| 2021-02-12 4:19 pm Purchase | 2020-12-31 | 13G | Axonics, Inc. AXNX | CREDIT SUISSE AG | 2,530,981 6.360% | 2,530,981 (New Position) | Filing History |
| 2021-02-12 12:33 pm Sale | 2020-12-31 | 13G | Axonics, Inc. AXNX | Flynn James E | 800,000 2.010% | -994,594 (-55.42%) | Filing History |
| 2021-02-08 10:17 am Purchase | 2021-02-05 | 13G | Axonics, Inc. AXNX | FMR LLC | 4,857,906 12.202% | 168,080 (+3.58%) | Filing History |
| 2021-02-08 10:00 am Sale | 2020-12-31 | 13G | Axonics, Inc. AXNX | Cooperatieve Gilde Healthcare IV U.A. | 1,376,733 3.500% | -1,756,599 (-56.06%) | Filing History |
| 2021-02-05 4:31 pm Sale | 2020-12-31 | 13G | Axonics, Inc. AXNX | INTEGRATED CORE STRATEGIES (US) LLC | 31,524 0.100% | -1,903,614 (-98.37%) | Filing History |